David Cordani - Feb 28, 2024 Form 4 Insider Report for Cigna Group (CI)

Role
Chairman & CEO, Director
Signature
Matthew Arnold, attorney-in-fact
Stock symbol
CI
Transactions as of
Feb 28, 2024
Transactions value $
$0
Form type
4
Date filed
3/1/2024, 07:44 PM
Previous filing
Feb 27, 2024
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +9.93K +2.95% $0.00 347K Feb 28, 2024 Direct F1
holding CI Common Stock, $.01 Par Value 1.73K Feb 28, 2024 By 401(k) F2
holding CI Common Stock, $.01 Par Value 99.9K Feb 28, 2024 By GRAT
holding CI Common Stock, $.01 Par Value 154K Feb 28, 2024 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +36.2K $0.00 36.2K Feb 28, 2024 Common Stock, $.01 Par Value 36.2K $336.48 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted shares vest in three equal annual installments beginning March 1, 2025.
F2 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
F3 This option vests in three equal annual installments beginning March 1, 2025.